Publiziert in: Marktpuls, Unternehmen
Frei

Reminder: Invitation to Roche's Virtual Late Stage Pipeline Event 2018 Montag, 03. September 2018 - 14:39

130612.jpg

 

We are pleased to invite investors and analysts to participate in a live video webcast and conference call on Thursday, 13 September 2018, highlighting development and commercial opportunities within our late stage portfolio.

The Roche Virtual Late Stage Pipeline Event will address the following topics:
-  Pharma strategy
-  Late stage new molecular entities in oncology, ophthalmology and infectious diseases
-  Late stage new molecular entities in neuroscience
-  Commercial opportunities


Speakers include Daniel O'Day, Sandra Horning, Paulo Fontoura and Alexander Hardy.


We would like to invite all interested parties to watch the live video webcast or to dial in as outlined below:

14:00 - 16:00 CEST / 13:00 - 15:00 BST
08:00 am - 10:00 am EDT / 05:00 am - 07:00 am PDT

Live video webcast and conference call will start with presentations by senior management followed by a Q&A session (questions can be asked via phone and webcast).

The
 live video webcast can be accessed via ir.roche.com.

In order to receive your personal dial-in details and expedite your access to the conference call, please pre-register under this 
link

If you have not pre-registered, please find the dial-in numbers below, we recommend you to dial in to the conference 10-15 min prior to the scheduled start.

+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)

Presentation slides and a replay of the webcast will be available via ir.roche.com

Best regards,

 

Karl Mahler 
Head of Investor Relations

Bruno Eschli
Investor Relations Officer

Roche Investor Relations

 

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: 
karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: 
sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: 
bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: 
birgit.masjost@roche.com

Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com

 

 

 

Investor Relations North America

 

Loren Kalm
Phone: +1 650 225 3217
e-mail: 
kalm.loren@gene.com